News NICE backs Alimera’s three-year uveitis implant An implant developed by Alimera Sciences has been recommended by NICE to treat an inflammatory eye disease that can cau
Partner Content Partner Content Your Latest Ophthalmology News for SMi’s Ophthalmic Drugs 20... Ophthalmic Drugs Conference London
News Moderna jab on trial for cancer-causing syndrome Patients with Lynch syndrome could have a potential treatment on the horizon, as a Moderna mRNA vaccine starts trials at Oxford University.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
